약물 코팅 풍선 카테터 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 용도별, 지역별 및 부문별 예측(2026-2033년)

Drug-coated Balloon Catheter Market Summary

The global drug-coated balloon catheter market size was estimated at USD 1.2 billion in 2025 and is projected to reach USD 2.3 billion by 2033, growing at a CAGR of 8.3% from 2026 to 2033. The rising prevalence of cardiovascular diseases and increasing incidence of coronary and peripheral artery disease continue to boost the need for practical, minimally invasive vascular interventions, which are key drivers of market growth.

According to Oxford Academic in January 2025, the global age-standardized prevalence of CVD is estimated at approximately 7,179 cases per 100,000 population, highlighting the persistent global burden of heart-related disorders. This high prevalence is driving demand for drug coated balloon catheters, which offer an effective, minimally invasive option for treating vascular narrowing and reducing restenosis in patients with coronary and peripheral artery disease, thereby supporting their growing adoption in interventional cardiology.

The market is witnessing strong growth driven by the rising prevalence of vascular diseases such as peripheral artery disease (PAD), increasing clinical adoption supported by superior outcomes over conventional balloons, and expanding use across hospitals and specialized cardiac centers. These devices offer effective revascularization without leaving permanent implants, making them a preferred minimally invasive treatment option. Advancements in imaging and the integration of AI-enabled procedural guidance are enhancing treatment precision and physician confidence, further accelerating the adoption of DCB technologies across interventional cardiology practices.

Increasing prevalence of Peripheral Artery Disease (PAD)

The increasing prevalence of Peripheral Artery Disease (PAD) remains a key driver of the drug-coated balloon (DCB) catheter industry. According to the American Limb Preservation Society. article published in July 2025, the projected 220% increase in peripheral artery disease (PAD) cases worldwide by 2050, with prevalence expected to rise from 113 million in 2021 to over 360 million, highlights a rapidly expanding patient population requiring vascular intervention. This rise is fuels demand for drug-coated balloon catheters, which are widely used in PAD treatment to restore vessel patency and reduce restenosis without leaving permanent implants, making them a preferred option for managing the growing PAD burden.

Global Drug-coated Balloon Catheter Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global drug-coated balloon catheter market report based on type, end use, and region:

• Type Outlook (Unit Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
• Coronary DCB
  • By Indication
  • In-Stent Restenosis (ISR)
  • De-novo coronary lesions
  • Complex / Adjunct Coronary Lesions
  • By Drug Type
  • Paclitaxel
  • Sirolimus
  • Others
• Peripheral DCB
  • By Indication
  • Femoropopliteal Artery Disease (PAD)
  • Below-the-Knee (BTK)
  • By Drug Type
  • Paclitaxel
  • Sirolimus
  • Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Specialty Cardiac/Vascular Centers
• Ambulatory Surgical Centers (ASCs)
• Regional Outlook (Unit Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • Indonesia
  • Malaysia
  • Vietnam
• Latin America
  • Brazil
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology And Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment Scope
  • 1.1.2. Estimates And Forecast Timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
  • 1.3.5. Details Of Primary Research
• 1.4. Information Or Data Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Drug-coated Balloon Catheter Market: Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type Outlook
  • 2.2.2. End Use Outlook
• 2.3. Competitive Insights

Chapter 3. Drug-coated Balloon Catheter Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
  • 3.2.3. Market Opportunity Analysis
• 3.3. Global Drug-coated Balloon Catheter: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Force Analysis
  • 3.3.2. PESTLE Analysis
• 3.4. Country-Level Market Driver Mapping (Coronary DCB)
• 3.5. Market Entry Attractiveness Assessment (Coronary DCB)

Chapter 4. Drug-coated Balloon Catheter Market Segment Analysis, By Type (Revenue in USD Million; Unit Volume in Thousand Units, 2021 - 2033)

• 4.1. Definition and Scope
• 4.2. Type Market Share Analysis, 2025 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Drug-coated Balloon Catheter Market By Type Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
  • 4.5.1. Coronary DCB
    • 4.5.1.1. Coronary DCB Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 4.5.1.2. Coronary DCB Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 4.5.1.3. By Indication
      • 4.5.1.3.1. In-Stent Restenosis (ISR)
        • 4.5.1.3.1.1. In-Stent Restenosis (ISR) Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.5.1.3.1.2. In-Stent Restenosis (ISR) Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.5.1.3.2. De-Novo Coronary Lesions
        • 4.5.1.3.2.1. De-Novo Coronary Lesions Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.5.1.3.2.2. De-Novo Coronary Lesions Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.5.1.3.3. Complex / Adjunct Coronary Lesions
        • 4.5.1.3.3.1. Complex / Adjunct Coronary Lesions Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.5.1.3.3.2. Complex / Adjunct Coronary Lesions Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 4.5.1.4. By Drug Type
      • 4.5.1.4.1. Paclitaxel
        • 4.5.1.4.1.1. Paclitaxel Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.5.1.4.1.2. Paclitaxel Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.5.1.4.2. Sirolimus
        • 4.5.1.4.2.1. Sirolimus Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.5.1.4.2.2. Sirolimus Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.5.1.4.3. Others
        • 4.5.1.4.3.1. Others Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.5.1.4.3.2. Others Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 4.5.2. Peripheral DCB
    • 4.5.2.1. Peripheral DCB Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 4.5.2.2. Peripheral DCB Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.5.2.2.1. By Indication
      • 4.5.2.2.2. Femoropopliteal Artery Disease (PAD)
        • 4.5.2.2.2.1. Femoropopliteal Artery Disease (PAD) Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.5.2.2.2.2. Femoropopliteal Artery Disease (PAD) Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.5.2.2.3. Below-the-Knee (BTK)
        • 4.5.2.2.3.1. Below-the-Knee (BTK) Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.5.2.2.3.2. Below-the-Knee (BTK) Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.5.2.2.4. By Drug Type
      • 4.5.2.2.5. Paclitaxel
        • 4.5.2.2.5.1. Paclitaxel Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.5.2.2.5.2. Paclitaxel Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.5.2.2.6. Sirolimus
        • 4.5.2.2.6.1. Sirolimus Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.5.2.2.6.2. Sirolimus Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.5.2.2.7. Others
        • 4.5.2.2.7.1. Others Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.5.2.2.7.2. Others Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)

Chapter 5. Drug-coated Balloon Catheter Market Segment Analysis, By End Use 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. End Use Market Share Analysis, 2025 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Drug-coated Balloon Catheter Market By End Use Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
  • 5.5.1. Hospitals
    • 5.5.1.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
  • 5.5.2. Cardiac Centers
    • 5.5.2.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
  • 5.5.3. Others
    • 5.5.3.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)

Chapter 6. Drug-coated Balloon Catheter Market Segment Analysis, By Region, (Revenue in USD Million; Unit Volume in Thousand Units, 2021 - 2033)

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Drug-coated Balloon Catheter Market Share by Region, 2025 & 2033:
• 6.5. North America
  • 6.5.1. North America Drug-coated Balloon Catheter Market, 2021 - 2033 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. U.S. Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.5.2.5. U.S. Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Canada Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.5.3.5. Canada Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.5.3.6. Canada Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Mexico Canada Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.5.4.5. Mexico Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.5.4.6. Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
• 6.6. Europe
  • 6.6.1. Europe Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. UK Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.6.2.5. Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.6.3. Germany
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Germany Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.6.3.5. Germany Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.6.4. France
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. France Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.6.5. Italy
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Italy Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.6.5.5. Italy Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.6.6. Spain
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Spain Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.6.6.5. Spain Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.6.7. Denmark
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Denmark Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.6.7.5. Denmark Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.6.8. Sweden
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Competitive Scenario
    • 6.6.8.3. Regulatory Framework
    • 6.6.8.4. Sweden Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.6.8.5. Sweden Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.6.9. Norway
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Competitive Scenario
    • 6.6.9.3. Regulatory Framework
    • 6.6.9.4. Norway Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.6.9.5. Norway Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
• 6.7. Asia Pacific
  • 6.7.1. China
    • 6.7.1.1. Key Country Dynamics
    • 6.7.1.2. Competitive Scenario
    • 6.7.1.3. Regulatory Framework
    • 6.7.1.4. China Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.7.1.5. China Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.7.2. Japan
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Japan Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.7.2.5. Japan Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.7.3. India
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. India Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.7.3.5. India Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.7.4. Australia
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. Australia Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.7.4.5. Australia Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.7.5. South Korea
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Framework
    • 6.7.5.4. South Korea Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.7.5.5. South Korea Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.7.6. Thailand
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Competitive Scenario
    • 6.7.6.3. Regulatory Framework
    • 6.7.6.4. Thailand Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.7.6.5. Thailand Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.7.7. Indonesia
    • 6.7.7.1. Key Country Dynamics
    • 6.7.7.2. Competitive Scenario
    • 6.7.7.3. Regulatory Framework
    • 6.7.7.4. Indonesia Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.7.7.5. Indonesia Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.7.8. Malaysia
    • 6.7.8.1. Key Country Dynamics
    • 6.7.8.2. Competitive Scenario
    • 6.7.8.3. Regulatory Framework
    • 6.7.8.4. Malaysia Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.7.8.5. Malaysia Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.7.9. Vietnam
    • 6.7.9.1. Key Country Dynamics
    • 6.7.9.2. Competitive Scenario
    • 6.7.9.3. Regulatory Framework
    • 6.7.9.4. Vietnam Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.7.9.5. Vietnam Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
• 6.8. Latin America
  • 6.8.1. Latin America Drug-coated Balloon Catheter Market, 2021 - 2033 (USD Million)
  • 6.8.2. Brazil
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Brazil Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.8.2.5. Brazil Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.8.3. Argentina
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. Argentina Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.8.3.5. Argentina Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.8.4. Colombia
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Competitive Scenario
    • 6.8.4.3. Regulatory Framework
    • 6.8.4.4. Colombia Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.8.4.5. Colombia Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.8.5. Chile
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Competitive Scenario
    • 6.8.5.3. Regulatory Framework
    • 6.8.5.4. Chile Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.8.5.5. Chile Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
• 6.9. MEA
  • 6.9.1. MEA Drug-coated Balloon Catheter Market, 2021 - 2033 (USD Million)
  • 6.9.2. South Africa
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Competitive Scenario
    • 6.9.2.3. Regulatory Framework
    • 6.9.2.4. South Africa Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.9.2.5. South Africa Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Competitive Scenario
    • 6.9.3.3. Regulatory Framework
    • 6.9.3.4. Saudi Arabia Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.9.3.5. Saudi Arabia Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.9.4. UAE
    • 6.9.4.1. Key Country Dynamics
    • 6.9.4.2. Competitive Scenario
    • 6.9.4.3. Regulatory Framework
    • 6.9.4.4. UAE Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.9.4.5. UAE Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key Country Dynamics
    • 6.9.5.2. Competitive Scenario
    • 6.9.5.3. Regulatory Framework
    • 6.9.5.4. Kuwait Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
    • 6.9.5.5. Kuwait Drug-coated Balloon Catheter Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company Categorization (Key innovators, market leaders, emerging players)
• 7.3. Company Market Position Analysis, 2025
• 7.4. Company Market Share Analysis, 2025/2026 (%)
• 7.5. Company Profiles
  • 7.5.1. Boston Scientific Corporation
    • 7.5.1.1. Company Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Medtronic
    • 7.5.2.1. Company Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. B. Braun Se
    • 7.5.3.1. Company Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Concept Medical
    • 7.5.4.1. Company Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. Abbott
    • 7.5.5.1. Company Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. Koninklijke Philips N.V.
    • 7.5.6.1. Company Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. Teleflex Incorporated (Biotronik)
    • 7.5.7.1. Company Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. Translumina
    • 7.5.8.1. Company Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. Microport Scientific Corporation
    • 7.5.9.1. Company Overview
    • 7.5.9.2. Financial Performance
    • 7.5.9.3. Product Benchmarking
    • 7.5.9.4. Strategic Initiatives
  • 7.5.10. Cardionovum Gmbh
    • 7.5.10.1. Company Overview
    • 7.5.10.2. Financial Performance
    • 7.5.10.3. Product Benchmarking
    • 7.5.10.4. Strategic Initiatives
  • 7.5.11. Ivascular S.L.U.
    • 7.5.11.1. Company Overview
    • 7.5.11.2. Financial Performance
    • 7.5.11.3. Product Benchmarking
    • 7.5.11.4. Strategic Initiatives
  • 7.5.12. Lepu Medical
    • 7.5.12.1. Company Overview
    • 7.5.12.2. Financial Performance
    • 7.5.12.3. Product Benchmarking
    • 7.5.12.4. Strategic Initiatives
  • 7.5.13. Meril Life Sciences Pvt. Ltd.
    • 7.5.13.1. Company Overview
    • 7.5.13.2. Financial Performance
    • 7.5.13.3. Product Benchmarking
    • 7.5.13.4. Strategic Initiatives
  • 7.5.14. Cordis
    • 7.5.14.1. Company Overview
    • 7.5.14.2. Financial Performance
    • 7.5.14.3. Product Benchmarking
    • 7.5.14.4. Strategic Initiatives
  • 7.5.15. Acotec Scientific (Acotec / Acotec Scientific AG)
    • 7.5.15.1. Company Overview
    • 7.5.15.2. Financial Performance
    • 7.5.15.3. Product Benchmarking
    • 7.5.15.4. Strategic Initiatives
  • 7.5.16. SMT
    • 7.5.16.1. Company Overview
    • 7.5.16.2. Financial Performance
    • 7.5.16.3. Product Benchmarking
    • 7.5.16.4. Strategic Initiatives